Clinical Research

Study Population

Add MICARDIS® Clinical Research to My Alerts (what's this?)

Print | Send to a friend

Inclusion Criteria

  • Type 2 diabetes mellitus (insulin and non-insulin treated, glycosylated haemoglobin [HbA1c] ≤ 10%)
  • Hypertension (seated systolic blood pressure/diastolic blood pressure >130/>80 mmHg or treated for hypertension)
  • Macroalbuminuria (≥700 mg/g creatinine)
  • Serum creatinine:
    • women 97–265 µmol/L (1.1–3.0 mg/dL)
    • men 115–285 µmol/L (1.3–3.2 mg/dL)

Exclusion Criteria

  • Type 1 diabetes mellitus
  • An increase of serum creatinine >30% between the screening and the end of run-in visit
  • Non-diabetic renal disease
  • Congestive heart failure (New York Heart Association III–IV)
  • Active coronary artery disease with a recent revascularization
  • Unstable angina
  • Hepatic impairment
  • Pregnant or nursing women; fertile women not using contraception

References

Toolbox

Calendar

Tools and Downloads

My Alerts

You will shortly be able to create your own personal alerts service bringing the latest MICARDIS® news and updates direct to your inbox. Watch this space for more information.